Literature DB >> 31961831

Perceptions of Stress: Patient and Caregiver Experiences With Stressors During Hospitalization.

Alham Abuatiq1, Robin Brown, Brenda Wolles2, Robin Randall3.   

Abstract

BACKGROUND: Hospitalization for a cancer diagnosis and treatment may trigger stressful experiences for patients and family caregivers.
OBJECTIVES: The purpose of this study was to identify patients' and caregivers' perceptions of stressors during hospitalization and evaluate their education needs.
METHODS: A descriptive correlational research design was used to determine whether there is any correlation between the stress perceptions of patients and family caregivers and their need for additional education on health-related issues.
FINDINGS: Patients reported experiencing mild to extreme stress for sleep deprivation, pain, tube and line restrictions, and financial issues. In addition to these stressors, family caregivers also perceived that waiting for test results was a main reason for stress in patients. A positive significant correlation was found between the total sample mean stress scores of patients and their need for additional education on health-related issues.

Entities:  

Keywords:  Patient education; caregivers; health-related issues; hospitalization; stressors

Mesh:

Year:  2020        PMID: 31961831     DOI: 10.1188/20.CJON.51-57

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  3 in total

1.  Matched pair analysis to evaluate the impact of hospitalization during radiation therapy as an early marker of survival in head and neck cancer patients.

Authors:  Hye Ri Han; Gregory M Hermann; Sung Jun Ma; Austin J Iovoli; Kimberly E Wooten; Hassan Arshad; Vishal Gupta; Ryan P McSpadden; Moni A Kuriakose; Michael R Markiewicz; Jon M Chan; Mary E Platek; Andrew D Ray; Fangyi Gu; Wesley L Hicks; Elizabeth A Repasky; Anurag K Singh
Journal:  Oral Oncol       Date:  2020-06-16       Impact factor: 5.337

2.  β2-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME.

Authors:  Hemn Mohammadpour; Cameron R MacDonald; Philip L McCarthy; Scott I Abrams; Elizabeth A Repasky
Journal:  Cell Rep       Date:  2021-10-26       Impact factor: 9.423

3.  Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity.

Authors:  Shipra Gandhi; Manu R Pandey; Elizabeth A Repasky; Marc S Ernstoff; Kristopher Attwood; Wenyan Ji; Agnieszka K Witkiewicz; Erik S Knudsen; Cheryl Allen; Joseph D Tario; Paul K Wallace; Carlos D Cedeno; Maria Levis; Suzanne Stack; Pauline Funchain; Joseph J Drabick; Mark J Bucsek; Igor Puzanov; Hemn Mohammadpour
Journal:  Clin Cancer Res       Date:  2020-10-30       Impact factor: 13.801

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.